Comparing the economic terms of biotechnology licenses from academic institutions with those between commercial firms
Sign Up to like & getrecommendations! Published in 2023 at "PLOS ONE"
DOI: 10.1371/journal.pone.0283887
Abstract: Licenses of drug-related biotechnologies from academic institutions to commercial firms are intended to promote practical applications of public sector research and a return on government investments in biomedical science. This empirical study compares the economic… read more here.
Keywords: commercial firms; academic institutions; licenses academic; biotechnology licenses ... See more keywords